Empire Company Limited Stock: price and insider trades · Canada
Who traded when
BuySale+2 other insiders
Analyst consensus: bullish or bearish?
Analysts rate Empire Company Limited Hold (neutral), based on 8 analysts. Average price target: CA$53.50.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended April 2026 · cache
- 10,586 sharesNon-Voting Shares Class ATSXSEDI:4798514
- 10,586 shares@ CA$49.8067Non-Voting Shares Class ATSXSEDI:4798511
- 35,000 sharesNon-Voting Shares Class ATSXSEDI:4798499
- 35,000 shares@ CA$49.9388Non-Voting Shares Class ATSXSEDI:4798496
- 31,200 sharesNon-Voting Shares Class ATSXSEDI:4798491
- 31,200 shares@ CA$49.9675Non-Voting Shares Class ATSXSEDI:4798489
- 700 sharesNon-Voting Shares Class ATSXSEDI:4798488
- 700 shares@ CA$50.00Non-Voting Shares Class ATSXSEDI:4798487
- 18,500 sharesNon-Voting Shares Class ATSXSEDI:4798485
- 18,500 shares@ CA$50.00Non-Voting Shares Class ATSXSEDI:4798483
- 4,100 sharesNon-Voting Shares Class ATSXSEDI:4798479
- 4,100 shares@ CA$49.9283Non-Voting Shares Class ATSXSEDI:4798478
- 35,000 sharesNon-Voting Shares Class ATSXSEDI:4798477
- 35,000 shares@ CA$48.8026Non-Voting Shares Class ATSXSEDI:4798476
- 35,000 sharesNon-Voting Shares Class ATSXSEDI:4798475
- 35,000 shares@ CA$49.1435Non-Voting Shares Class ATSXSEDI:4798474
- 35,000 sharesNon-Voting Shares Class ATSXSEDI:4798473
- 35,000 shares@ CA$49.0755Non-Voting Shares Class ATSXSEDI:4798472
- 35,000 sharesNon-Voting Shares Class ATSXSEDI:4798466
- 35,000 shares@ CA$49.3043Non-Voting Shares Class ATSXSEDI:4798463
- 35,000 sharesNon-Voting Shares Class ATSXSEDI:4798458
- 35,000 shares@ CA$49.0661Non-Voting Shares Class ATSXSEDI:4798456
- 54,700 sharesNon-Voting Shares Class ATSXSEDI:4798454
- 54,700 shares@ CA$47.9778Non-Voting Shares Class ATSXSEDI:4798449
- 55,000 sharesNon-Voting Shares Class ATSXSEDI:4798445
25 of 2697 declarations
About Empire Company Limited
In the record for Empire Company Limited, the company itself, as issuer, files 1,456 of the 1,997 filings, with no purchase and no sale, and 1,577 filings are of a kind other than an open-market purchase or sale. On the market side: 156 sales worth EUR 28.3 million (median EUR 26,112) and 104 purchases worth EUR 3.7 million (median EUR 11,912), or 40% purchases.
Michael Bennett Medline, a director and senior officer of the issuer, accounts for much of it: 81 filings, of which 56 purchases and 10 sales. He made the three largest sales, all in 2025: EUR 1,898,930 on April 28, EUR 1,596,200 on July 10 and EUR 1,594,233 on June 24. The largest purchases are James Malcolm Dickson's (director), EUR 363,160 on June 24, 2024, and Paul David Sobey's, EUR 215,778 on January 17, 2020. Between October 15 and October 29, 2018, 4 insiders bought for EUR 264,049.
Read moreShow less
The filings, from 45 insiders, are published from September 29, 2015 to October 19, 2026, with a median delay of 13 days. 2025 is the busiest year (433). This Canadian food and beverage company is worth CAD 11.4 billion. Over the last twelve months: 223 filings, 4 purchases, 11 sales. For 102 purchases a 90-day result is stored: a median of 24.9%, with 85% of results positive, recorded past results and not a forecast.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
